ANXA1 and hairy cell leukemia: HCL variant (HCLv), recognized as a separate disorder [3, 7, 8], generally lacks CD25, CD123, annexin A1, TRAP, and BRAF V600E, responds more poorly to therapy, and survival from diagnosis is shorter [2, 9–12].